GLP-1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids.
Hoekx CA, Brinkman LBD, van Eenige R, Kooijman S, Muskiet M et al.
South Asian adults showed biphasic glucose response to meals versus monophasic response in European adults, with sex-specific differences in GLP-1, GIP, and glucagon patterns despite similar BMI. Mixed meal tolerance test in 49 young, lean adults (24 South Asian, 25 European) over 240 minutes. This represents first detailed comparison of incretin hormone responses between these populations, revealing distinct metabolic phenotypes that could affect GLP-1 therapy responses. The findings suggest South Asians may need different dosing strategies or combination approaches for optimal glycemic control.
Strategic Signal
The biphasic glucose response and altered incretin patterns in South Asians could require population-specific clinical development for GLP-1 therapies. Regulatory agencies may demand ethnicity-specific efficacy data, particularly as South Asian populations represent large markets in the US, UK, and globally. This mirrors earlier concerns about differential SGLT2 responses across ethnic groups that led to label modifications. Companies developing oral GLP-1s like Eli Lilly's orforglipron may need additional studies to demonstrate comparable efficacy across populations.